COHERUS BIOSCIENCES INC (CHRS) Top Institutional Shareholders
COHERUS BIOSCIENCES INC (CHRS) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended March 31, 2026. The institutional investors covered on this page collectively reported approximately $95.51M in CHRS holdings during the latest filing period.
Blackrock, Inc. is currently the largest disclosed institutional shareholder of CHRS tracked by InsiderSet, reporting ownership valued at approximately $17.52M in its March 31, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $14.41M, representing an estimated loss of -17.75% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 64% of the total disclosed CHRS value among the investors covered in this analysis. Major shareholders include Blackrock, Inc., Vanguard Capital Management Llc, Samsara Biocapital, Llc, and several other long-term asset managers with concentrated positions in COHERUS BIOSCIENCES INC (CHRS).
This page ranks the largest institutional CHRS shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
154
Total Reported Value
$95.51M
Largest Holder
Blackrock, Inc.
Largest Position
$17.52M
Insider Transactions (90d)
0
Latest Filing Quarter
Q1 2026
New Institutional Positions
167
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Blackrock, Inc. | 0.00% | 10,365,074 | $17,516,975 | $14,407,453 | -$3,109,522 | -17.75% | |
| Vanguard Capital Management Llc | 0.00% | 5,452,762 | $9,215,168 | $7,579,339 | -$1,635,829 | -17.75% | |
| Samsara Biocapital, Llc | 0.56% | 3,428,571 | $5,794,285 | $4,765,714 | -$1,028,571 | -17.75% | |
| Geode Capital Management, Llc | 0.00% | 3,121,578 | $5,276,839 | $4,338,993 | -$937,846 | -17.77% | |
| Kohlberg Kravis Roberts & Co. L.P. | 0.09% | 3,036,076 | $5,065,315 | $4,220,146 | -$845,169 | -16.69% | |
| State Street Corp | 0.00% | 2,325,859 | $3,930,702 | $3,232,944 | -$697,758 | -17.75% | |
| Two Sigma Investments, Lp | 0.00% | 2,302,001 | $3,890,382 | $3,199,781 | -$690,601 | -17.75% | |
| Alyeska Investment Group, L.P. | 0.01% | 2,250,000 | $3,802,500 | $3,127,500 | -$675,000 | -17.75% | |
| Cm Management, Llc | 2.97% | 2,100,000 | $3,549,000 | $2,919,000 | -$630,000 | -17.75% | |
| Tang Capital Management Llc | 0.16% | 1,886,748 | $3,188,604 | $2,622,580 | -$566,024 | -17.75% | |
| Hudson Bay Capital Management Lp | 0.02% | 1,704,980 | $2,881,416 | $2,369,922 | -$511,494 | -17.75% | |
| Panagora Asset Management Inc | 0.01% | 1,459,310 | $2,466,234 | $2,028,441 | -$437,793 | -17.75% | |
| Propel Bio Management, Llc | 1.52% | 1,420,550 | $2,413,387 | $1,974,564 | -$438,823 | -18.18% | |
| Aqr Capital Management Llc | 0.00% | 1,206,046 | $2,038,217 | $1,676,404 | -$361,813 | -17.75% | |
| Charles Schwab Investment Management Inc | 0.00% | 1,155,901 | $1,953,473 | $1,606,702 | -$346,771 | -17.75% | |
| Vanguard Fiduciary Trust Co | 0.00% | 949,919 | $1,605,363 | $1,320,387 | -$284,976 | -17.75% | |
| Northern Trust Corp | 0.00% | 913,800 | $1,544,322 | $1,270,182 | -$274,140 | -17.75% | |
| Nomura Asset Management International Inc. | 0.00% | 899,999 | $1,521,000 | $1,250,999 | -$270,001 | -17.75% | |
| Goldman Sachs Group Inc | 0.00% | 696,158 | $1,176,507 | $967,660 | -$208,847 | -17.75% | |
| Vanguard Portfolio Management Llc | 0.00% | 604,525 | $1,021,647 | $840,290 | -$181,357 | -17.75% | |
| Ubs Group Ag | 0.00% | 547,209 | $924,783 | $760,621 | -$164,162 | -17.75% | |
| Sei Investments Co | 0.00% | 453,763 | $766,859 | $630,731 | -$136,128 | -17.75% | |
| Bridgeway Capital Management, Llc | 0.01% | 441,000 | $745,290 | $612,990 | -$132,300 | -17.75% | |
| Invesco Ltd. | 0.00% | 335,309 | $566,672 | $466,080 | -$100,592 | -17.75% | |
| Renaissance Technologies LLC | Jim Simons | 0.00% | 331,700 | $560,573 | $461,063 | -$99,510 | -17.75% |
| Bank Of America Corp | 0.00% | 324,133 | $547,786 | $450,545 | -$97,241 | -17.75% | |
| Strs Ohio | 0.00% | 324,000 | $547,560 | $450,360 | -$97,200 | -17.75% | |
| Millennium Management Llc | 0.00% | 311,986 | $527,256 | $433,661 | -$93,595 | -17.75% | |
| Informed Momentum Co Llc | 0.06% | 309,801 | $523,564 | $430,623 | -$92,941 | -17.75% | |
| Susquehanna International Group, Llp | 0.00% | 287,500 | $485,875 | $399,625 | -$86,250 | -17.75% | |
| Bank Of New York Mellon Corp | 0.00% | 285,033 | $481,706 | $396,196 | -$85,510 | -17.75% | |
| Marshall Wace, Llp | 0.00% | 270,087 | $456,447 | $375,421 | -$81,026 | -17.75% | |
| Simplify Asset Management Inc. | 0.01% | 253,140 | $427,807 | $351,865 | -$75,942 | -17.75% | |
| Jefferies Financial Group Inc. | 0.01% | 252,000 | $425,880 | $350,280 | -$75,600 | -17.75% | |
| Tyche Wealth Partners Llc | 0.06% | 240,868 | $407,067 | $334,807 | -$72,260 | -17.75% | |
| Citadel Advisors Llc | 0.00% | 233,946 | $395,369 | $325,185 | -$70,184 | -17.75% | |
| Nuveen, Llc | 0.00% | 210,379 | $355,541 | $292,427 | -$63,114 | -17.75% | |
| Morgan Stanley | 0.00% | 197,511 | $333,793 | $274,540 | -$59,253 | -17.75% | |
| Barclays Plc | 0.00% | 195,473 | $330,350 | $271,707 | -$58,643 | -17.75% | |
| Squarepoint Ops Llc | 0.00% | 194,405 | $328,544 | $270,223 | -$58,321 | -17.75% | |
| Alliancebernstein L.P. | 0.00% | 213,590 | $303,298 | $296,890 | -$6,408 | -2.11% | |
| Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main | 0.00% | 159,990 | $270,383 | $222,386 | -$47,997 | -17.75% | |
| Envestnet Asset Management Inc | 0.00% | 152,194 | $257,208 | $211,550 | -$45,658 | -17.75% | |
| Rhumbline Advisers | 0.00% | 125,101 | $211,410 | $173,890 | -$37,520 | -17.75% | |
| Ieq Capital, Llc | 0.00% | 121,967 | $206,124 | $169,534 | -$36,590 | -17.75% | |
| Lpl Financial Llc | 0.00% | 120,796 | $204,145 | $167,906 | -$36,239 | -17.75% | |
| Summit Financial, Llc | 0.00% | 112,088 | $189,429 | $155,802 | -$33,627 | -17.75% | |
| Group One Trading Llc | 0.01% | 111,791 | $188,927 | $155,389 | -$33,538 | -17.75% | |
| Shay Capital Llc | 0.03% | 105,326 | $178,001 | $146,403 | -$31,598 | -17.75% | |
| Headlands Technologies Llc | 0.02% | 100,272 | $169,460 | $139,378 | -$30,082 | -17.75% |
Frequently asked questions about CHRS
Who owns the most CHRS stock?
The largest holders of CHRS are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for COHERUS BIOSCIENCES INC (CHRS).
Is CHRS widely held by superinvestors?
Many widely followed stocks like CHRS appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly CHRS is represented among the institutional managers we track.
What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?
Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.